Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.

Journal: Cell

Published: 2020-01-23

DOI: 10.1016/j.cell.2020.01.010

Affiliations: 16

Authors: 25

Go to article
Institutions Share
University Hospital of Cologne, Germany 0.29
Division of Biology and Biological Engineering (BBE), Caltech, United States of America (USA) 0.16
Institute of Virology, UoC, Germany 0.11
Laboratory of Experimental Immunology, UoC, Germany 0.11
DZIF Partner Site Bonn-Cologne, Germany 0.08
Herbold Computational Biology Program, FHCRC, United States of America (USA) 0.08
Department of Medical Microbiology, UvA, Netherlands 0.06
Center for Virology and Vaccine Research, BIDMC, United States of America (USA) 0.04
Center for Molecular Medicine Cologne (CMMC), UoC, Germany 0.03
Department of Microbiology and Immunology, Cornell University, United States of America (USA) 0.02
University Hospital Frankfurt, GU, Germany 0.01
Centre for Clinical Trials Cologne (ZKS Köln), UoC, Germany 0.01
Cluster of Excellence - Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), UoC, Germany 0.01
Howard Hughes Medical Institute (HHMI), United States of America (USA) 0

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER